TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/11/23 18:26 | 1/9/23 | VYGR | Voyager Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ecor1 Capital, LLC | CA | T | S.m | -7,142 | 7.91 | 0 | -902 | -19 | 3,852 | I | |||||||||||||||
5/9/22 06:04 | 5/5/22 | ANAB | Anaptysbio, Inc | DE | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | T | S | -14,454 | 21.63 | 0 | -668 | -4 | 15,042 | I | |||||||||||||||
5/9/22 06:01 | 5/5/22 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | T | S | -30,841 | 29.02 | 0 | -1,063 | -4 | 23,169 | I | |||||||||||||||
12/10/21 18:50 | 12/1/21 | ODT | Odonate Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | T | S.m | -9,741 | 1.65 | 0 | -5,888 | -100 | 0 | I | |||||||||||||||
10/1/21 19:39 | 9/30/21 | CRVS | Corvus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | T | S.m | -25,060 | 5.01 | 0 | -5,000 | -98 | 81 | I | |||||||||||||||
9/3/20 16:17 | 9/1/20 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ecor1 Capital, LLC | CA | T | S | -2,377 | 7.14 | 0 | -333 | -7 | 4,701 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |